Our IBD specialists are dedicated to identifying causes of IBD, improving the diagnosis, and investigating new treatments for IBD


All of our gastroenterologists at the IBD Clinic actively participate in research. Please refer to the IBD Research and Ongoing research projects for more information.

As a patient, you may be asked to participate in a research study conducted in our IBD Clinic. Participation in research is voluntary. We do, however, appreciate your willingness to participate.

As an individual, you can also contribute to our research through donations or make a donation on behalf of someone.

Clinical Trials

The IBD Clinic runs clinical trials to investigate the efficacy of experimental medications and other treatments that are unavailable elsewhere. This provides an opportunity for patients who have exhausted commercially available medications. Ask your gastroenterologist or nurse at the IBD Clinic about clinical trials that may be appropriate for you.

The Gastrointestinal and Liver Disease Research Group (GILDR) is an experienced team of administration and research staff, working directly with gastroenterologists and hepatologists at the Alberta Health Services and University of Alberta to ensure the high standard of clinical trials and patient safety and close monitoring.

GILDR group conducts world-class clinical trials investigating the efficacy of new medications and treatments for IBD. In Canada, we are one of the few centers that have the expertise and resources to conduct high-quality trials and are frequently involved in assessing leading edge therapies in gastrointestinal diseases including IBD.

More information about GILDR can be found here.

Contact

Sharon Appelman-Eszczuk, Director of Operations

Email: sharon.appelman@ualberta.ca

Phone: 780-492-8602     Fax: 780-492-8116

 

Basic research

The Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR) brings together internationally recognized specialists in basic and clinical sciences and their research teams. They are actively involved in studying microbiome, genetic abnormalities and environmental factors associated with IBD.

CEGIIR is a multidisciplinary research centre devoted to understanding the genetic and environmental causes of inflammatory diseases, such as IBD. It is comprised of world-class researchers and clinician-researchers, trainees, and visiting researchers.

To learn more about CEGIIR members, and its activities, click here.

If you are interested in participating in our clinical trials, please refer to Can I take part in clinical trials?

Contact

Naomi Hotte, Program Manager

Email: nhotte@ualberta.ca

Phone: 780-492-7077

 

Lindsy Ambrosio, Clinical Research Coordinator

Email: ambrosio@ualberta.ca

Phone: 780-492-1036

 

Mailing address:

CEGIIR, Division of Gastroenterology

Katz Group-Rexall Centre, Edmonton, AB, Canada T6G 2E1

Fax: 780-492-7593

 

Northern Alberta Clinical Trials and Research Centre (NACTRC)

Established in 1999, the Northern Alberta Clinical Trials and Research Centre (NACTRC) serves as an integrated network connecting main hospitals and primary care centers with pharmaceutical and research companies. The NACTRC provides comprehensive administrative support for researchers and ensures the highest standards are met.

This organization is a joint effort between Alberta Health Services, academic institutes, and industry. NACTRC brings together researchers, physicians, and participants to investigate the safety and efficacy of new medications.

For more information about trials currently recruiting patients and/or healthy individuals to participate, please consult NACTRC.